Results 151 to 160 of about 41,603 (297)
Emphysematous pyelonephritis with perinephric extension and fistulous communication to the descending colon: a rare CT imaging diagnosis. [PDF]
Gaikwad S, Thotwe E.
europepmc +1 more source
Cellular neurilemoma (schwannoma) of the descending colon mimicking carcinoma: report of a case
We report a rare case of a cellular neurilemoma (schwannoma) of the descending colon, mimicking carcinoma, not accompanied by von Recklinghausen's disease.
Mylonakis, E. P. +3 more
core
ABSTRACT This study aimed to investigate the mechanism of ophiopogonin D (OD) in treating primary Sjögren's syndrome (pSS) through integrated analysis of gut microbiota and metabolomics. Non‐obese diabetic/LtJ mice, a well‐established pSS model, were used as the model group and treated with OD or hydroxychloroquine.
Fengtao Pang +3 more
wiley +1 more source
Ultrasonographic features of 5-aminosalicylic acid intolerance in pediatric ulcerative colitis. [PDF]
Murashige H +3 more
europepmc +1 more source
Papillary Adenocarcinoma of the descending colon in a dog: case report
The aim of this report was to describe the clinical findings and therapeutic management of a case of papillary adenocarcinoma of the descending colon in a Beagle. The patient presented soft stools, haematochezia, tenesmus, and dyschezia.
J.O. Ribeiro +12 more
core +1 more source
Return of the Megaureter: A Sequel no One Expected an Enigmatic Case of Ureteral Stump Syndrome
ABSTRACT This paper aims to emphasize the importance of not underestimating the potential complications of subtotal ureterectomy, despite their rarity. Ureteral Stump Syndrome can present with signs and symptoms that are not easily interpreted, and the range of differential diagnoses is broad and multidisciplinary.
Virginia Filippini +4 more
wiley +1 more source
Adult Descending Colon Duplication Mimicking Colon Cancer: A Rare Case Report. [PDF]
Oyama S +3 more
europepmc +1 more source
Efficacy of Disitamab Vedotin in Treating HER2 2+/FISH‐Bladder Cancer: A Case Report
Timeline of treatment and sustained partial response in a patient with HER2 2+/FISH‐ bladder cancer (October 2019 – June 2024). ABSTRACT Disitamab Vedotin achieved durable partial response (> 8 months PFS) in advanced HER2 2+/FISH‐ bladder cancer after first‐line chemo‐immunotherapy progression.
Zhi‐ruo Jin +8 more
wiley +1 more source

